PVLA Palvella Therapeutics, Inc.
$145.77
Palvella Therapeutics, Inc. (PVLA) Earnings News
Earnings press releases, previews and reviews for Palvella Therapeutics, Inc. (PVLA), newest first. Our most recent is review: Palvella's Narrow Miss Is a Sideshow: Priority Review Sets a February 2027 Verdict as Launch Spending Accelerates.
Thursday
November 5, 2026
11:58 AM ET
Palvella's Narrow Miss Is a Sideshow: Priority Review Sets a February 2027 Verdict as Launch Spending Accelerates
Earnings Whispers · Review
Thursday
November 5, 2026
7:30 AM ET
Palvella Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Thursday
October 29, 2026
11:59 AM ET
Palvella's Q3 Report Hinges on NDA Completion Timing and Disciplined Launch Spending
Earnings Whispers · Preview
Thursday
October 29, 2026
7:30 AM ET
Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026
Tuesday
August 4, 2026
7:30 AM ET
Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Tuesday
July 28, 2026
7:30 AM ET
Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026